Search

Sean E. Aeder

Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1939
Issued Applications
907
Pending Applications
201
Abandoned Applications
855

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7168209 [patent_doc_number] => 20050201978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Tumor and infectious disease therapeutic compositions' [patent_app_type] => utility [patent_app_number] => 10/991049 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20493 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20050201978.pdf [firstpage_image] =>[orig_patent_app_number] => 10991049 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/991049
Tumor and infectious disease therapeutic compositions Nov 16, 2004 Abandoned
Array ( [id] => 5230862 [patent_doc_number] => 20070292970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Method for Distinguishing Aml-Specific Flt3 Length Mutations From Tkd Mutations' [patent_app_type] => utility [patent_app_number] => 10/575600 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40976 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292970.pdf [firstpage_image] =>[orig_patent_app_number] => 10575600 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/575600
Method for Distinguishing Aml-Specific Flt3 Length Mutations From Tkd Mutations Nov 3, 2004 Abandoned
Array ( [id] => 5259102 [patent_doc_number] => 20070212734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Method for Distinguishing T(11Q23)/Mll-Positive Leukemias From t(11Q23)/Mll Negative Leukemia' [patent_app_type] => utility [patent_app_number] => 10/575805 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19022 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212734.pdf [firstpage_image] =>[orig_patent_app_number] => 10575805 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/575805
Method for Distinguishing T(11Q23)/Mll-Positive Leukemias From t(11Q23)/Mll Negative Leukemia Nov 3, 2004 Abandoned
Array ( [id] => 132258 [patent_doc_number] => 07695899 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Methods of identifying and using chemotherapeutic agents' [patent_app_type] => utility [patent_app_number] => 10/978206 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8228 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/695/07695899.pdf [firstpage_image] =>[orig_patent_app_number] => 10978206 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/978206
Methods of identifying and using chemotherapeutic agents Oct 28, 2004 Issued
Array ( [id] => 860087 [patent_doc_number] => 07371527 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-05-13 [patent_title] => 'Hypermethylation of GATA-4 and GATA-5 transcription factor genes in cancer' [patent_app_type] => utility [patent_app_number] => 10/972066 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 13 [patent_no_of_words] => 25425 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371527.pdf [firstpage_image] =>[orig_patent_app_number] => 10972066 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/972066
Hypermethylation of GATA-4 and GATA-5 transcription factor genes in cancer Oct 20, 2004 Issued
Array ( [id] => 314664 [patent_doc_number] => 07524634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'MN/CA IX and cancer prognosis' [patent_app_type] => utility [patent_app_number] => 10/575300 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 13890 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524634.pdf [firstpage_image] =>[orig_patent_app_number] => 10575300 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/575300
MN/CA IX and cancer prognosis Oct 17, 2004 Issued
Array ( [id] => 5716081 [patent_doc_number] => 20060079444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Human Sef isoforms and methods of using same for cancer gene therapy' [patent_app_type] => utility [patent_app_number] => 10/963439 [patent_app_country] => US [patent_app_date] => 2004-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18310 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079444.pdf [firstpage_image] =>[orig_patent_app_number] => 10963439 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/963439
Human Sef isoforms and methods of using same for cancer gene therapy Oct 10, 2004 Abandoned
Array ( [id] => 7773539 [patent_doc_number] => 08119340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia' [patent_app_type] => utility [patent_app_number] => 10/575671 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15379 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 290 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119340.pdf [firstpage_image] =>[orig_patent_app_number] => 10575671 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/575671
Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia Oct 7, 2004 Issued
Array ( [id] => 5056784 [patent_doc_number] => 20070059706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Materials and methods relating to breast cancer classification' [patent_app_type] => utility [patent_app_number] => 10/574392 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26920 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059706.pdf [firstpage_image] =>[orig_patent_app_number] => 10574392 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/574392
Materials and methods relating to breast cancer classification Sep 30, 2004 Abandoned
Array ( [id] => 6939080 [patent_doc_number] => 20050112643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Atr-2 cell cycle checkpoint' [patent_app_type] => utility [patent_app_number] => 10/954723 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20105 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112643.pdf [firstpage_image] =>[orig_patent_app_number] => 10954723 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/954723
Atr-2 cell cycle checkpoint Sep 29, 2004 Abandoned
Array ( [id] => 307234 [patent_doc_number] => 07531300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Method of diagnosing breast cancer' [patent_app_type] => utility [patent_app_number] => 10/573297 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 36366 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531300.pdf [firstpage_image] =>[orig_patent_app_number] => 10573297 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/573297
Method of diagnosing breast cancer Sep 23, 2004 Issued
Array ( [id] => 6944360 [patent_doc_number] => 20050196409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Compositions of botanical extracts for treating malignancy-associated changes' [patent_app_type] => utility [patent_app_number] => 10/949178 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 14962 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20050196409.pdf [firstpage_image] =>[orig_patent_app_number] => 10949178 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/949178
Compositions of botanical extracts for treating malignancy-associated changes Sep 23, 2004 Abandoned
Array ( [id] => 848894 [patent_doc_number] => 07381410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Polypeptide compounds for inhibiting angiogenesis and tumor growth' [patent_app_type] => utility [patent_app_number] => 10/949720 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 110 [patent_figures_cnt] => 135 [patent_no_of_words] => 51197 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381410.pdf [firstpage_image] =>[orig_patent_app_number] => 10949720 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/949720
Polypeptide compounds for inhibiting angiogenesis and tumor growth Sep 22, 2004 Issued
Array ( [id] => 7075264 [patent_doc_number] => 20050148532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => '14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types' [patent_app_type] => utility [patent_app_number] => 10/938387 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25977 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148532.pdf [firstpage_image] =>[orig_patent_app_number] => 10938387 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/938387
14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types Sep 9, 2004 Issued
Array ( [id] => 7216748 [patent_doc_number] => 20050054665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Treatment for CD5+ B cell lymphoma' [patent_app_type] => utility [patent_app_number] => 10/933594 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10864 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054665.pdf [firstpage_image] =>[orig_patent_app_number] => 10933594 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/933594
Treatment for CD5+ B cell lymphoma Sep 2, 2004 Abandoned
Array ( [id] => 7018762 [patent_doc_number] => 20050220781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'IFIX, a novel HIN-200 protein, for cancer therapy' [patent_app_type] => utility [patent_app_number] => 10/934861 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 40418 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20050220781.pdf [firstpage_image] =>[orig_patent_app_number] => 10934861 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/934861
IFIX, a novel HIN-200 protein, for cancer therapy Sep 2, 2004 Abandoned
Array ( [id] => 7083241 [patent_doc_number] => 20050048621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Genetically altered antibody-producing cell lines with improved antibody characteristics' [patent_app_type] => utility [patent_app_number] => 10/933034 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15308 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048621.pdf [firstpage_image] =>[orig_patent_app_number] => 10933034 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/933034
Genetically altered antibody-producing cell lines with improved antibody characteristics Sep 1, 2004 Issued
Array ( [id] => 7122360 [patent_doc_number] => 20050014189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Reagents and methods useful for detecting diseases of the gastrointestinal tract' [patent_app_type] => utility [patent_app_number] => 10/926217 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 36528 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014189.pdf [firstpage_image] =>[orig_patent_app_number] => 10926217 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/926217
Reagents and methods useful for detecting diseases of the gastrointestinal tract Aug 24, 2004 Abandoned
Array ( [id] => 7083209 [patent_doc_number] => 20050048589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Lung cancer specific gene products: their coding sequence, their antibodies and their use in diagnostic, therapeutic and disease management of lung cancer' [patent_app_type] => utility [patent_app_number] => 10/926543 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 19115 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048589.pdf [firstpage_image] =>[orig_patent_app_number] => 10926543 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/926543
Lung cancer specific gene products: their coding sequence, their antibodies and their use in diagnostic, therapeutic and disease management of lung cancer Aug 24, 2004 Abandoned
Array ( [id] => 7121987 [patent_doc_number] => 20050013816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Modulators of the function of FAS/AP01 receptors' [patent_app_type] => utility [patent_app_number] => 10/923031 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17263 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20050013816.pdf [firstpage_image] =>[orig_patent_app_number] => 10923031 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/923031
Modulators of the function of FAS/APO1 receptors Aug 22, 2004 Issued
Menu